Latex sensitisation and allergy in children with myelomeningocele

C Rendeli1, E Nucera, E Ausili

  • 1Paediatric Department, Spina Bifida Centre, Policlinico A. Gemelli, Largo A. Gemelli 8, 00168 Rome, Italy. c.rendeli@libero.it

Insights

Children with spina bifida (SB) face high latex exposure, leading to frequent allergic reactions. This study found 48% sensitization and 15% allergy in myelomeningocele (MMC) patients, highlighting the need for latex-safe environments.

Area of Science:

  • Pediatric Allergy and Immunology
  • Developmental Pediatrics

Background:

  • Children with spina bifida (SB) experience significant exposure to latex products due to frequent medical interventions.
  • This increased exposure leads to a higher incidence of latex allergic reactions in this vulnerable population.

Purpose of the Study:

  • To determine the prevalence of latex sensitization and allergy in children with myelomeningocele (MMC).
  • To identify risk factors associated with latex allergy in this cohort.

Main Methods:

  • Evaluated latex sensitization using specific IgE levels (radioallergosorbent test [RAST]).
  • Assessed clinical manifestations of latex allergy.
  • Analyzed correlations between sensitization/allergy and factors like total IgE (paper radioimmunosorbent test [PRIST]), surgical history, and allergy familiarity.

Main Results:

  • 48% of patients (29/60) exhibited latex sensitization (specific IgE >0.7 kU/l).
  • 15% of patients (9/60) were clinically diagnosed with latex allergy.
  • Elevated specific serum IgE to latex (RAST) was the primary factor correlated with allergy (p<0.01), followed by total IgE (PRIST), number of surgeries, and allergy familiarity.

Conclusions:

  • The high prevalence of latex sensitization and allergy in children with MMC underscores the critical need for preventative strategies.
  • Implementing latex-safe protocols in healthcare settings and daily life is essential to mitigate risks of severe allergic reactions.
Abstract

Related Concept Videos